Abrdn World Healthcare Fund (NYSE:THW – Get Free Report) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 9,180 shares, a decrease of 63.3% from the August 15th total of 24,996 shares. Based on an average daily volume of 131,330 shares, the days-to-cover ratio is currently 0.1 days.
Hedge Funds Weigh In On Abrdn World Healthcare Fund
A number of hedge funds and other institutional investors have recently bought and sold shares of THW. Allied Private Wealth LLC acquired a new position in shares of Abrdn World Healthcare Fund in the 2nd quarter worth approximately $27,000. Advisory Services Network LLC bought a new stake in Abrdn World Healthcare Fund in the third quarter valued at about $43,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Abrdn World Healthcare Fund in the second quarter valued at approximately $113,000. Mercer Global Advisors Inc. ADV bought a new position in Abrdn World Healthcare Fund in the 4th quarter valued at $157,000. Finally, HighTower Advisors LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter worth $168,000.
Abrdn World Healthcare Fund Trading Down 0.9%
Shares of NYSE:THW traded down $0.12 during trading on Friday, reaching $13.38. The company had a trading volume of 67,388 shares, compared to its average volume of 134,384. The stock’s fifty day moving average price is $13.68 and its 200 day moving average price is $12.91. Abrdn World Healthcare Fund has a fifty-two week low of $11.18 and a fifty-two week high of $14.50.
Abrdn World Healthcare Fund Announces Dividend
About Abrdn World Healthcare Fund
Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.
The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.
Further Reading
- Five stocks we like better than Abrdn World Healthcare Fund
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Abrdn World Healthcare Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn World Healthcare Fund and related companies with MarketBeat.com's FREE daily email newsletter.
